These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18054829)

  • 1. A novel way to investigate the effects of plasma exchange on antibiotic levels: use of microdialysis.
    Roberts JA; Roberts MS; Robertson TA; Cross SE; Lipman J
    Int J Antimicrob Agents; 2008 Mar; 31(3):240-4. PubMed ID: 18054829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
    Roberts JA; Roberts MS; Robertson TA; Dalley AJ; Lipman J
    Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia.
    Boselli E; Breilh D; Rimmelé T; Guillaume C; Xuereb F; Saux MC; Bouvet L; Chassard D; Allaouchiche B
    Crit Care Med; 2008 May; 36(5):1500-6. PubMed ID: 18434883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients.
    Rafati MR; Rouini MR; Mojtahedzadeh M; Najafi A; Tavakoli H; Gholami K; Fazeli MR
    Int J Antimicrob Agents; 2006 Aug; 28(2):122-7. PubMed ID: 16815689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration.
    Varghese JM; Jarrett P; Boots RJ; Kirkpatrick CM; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2014 Apr; 43(4):343-8. PubMed ID: 24612982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.
    Roberts JA; Kirkpatrick CM; Roberts MS; Robertson TA; Dalley AJ; Lipman J
    J Antimicrob Chemother; 2009 Jul; 64(1):142-50. PubMed ID: 19398460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily serum piperacillin monitoring is advisable in critically ill patients.
    Blondiaux N; Wallet F; Favory R; Onimus T; Nseir S; Courcol RJ; Durocher A; Roussel-Delvallez M
    Int J Antimicrob Agents; 2010 May; 35(5):500-3. PubMed ID: 20226635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock.
    Joukhadar C; Frossard M; Mayer BX; Brunner M; Klein N; Siostrzonek P; Eichler HG; Müller M
    Crit Care Med; 2001 Feb; 29(2):385-91. PubMed ID: 11246321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of free extracellular concentrations of piperacillin by microdialysis.
    Nolting A; Costa TD; Vistelle R; Rand KH; Derendorf H
    J Pharm Sci; 1996 Apr; 85(4):369-72. PubMed ID: 8901070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does consistent piperacillin dosing result in consistent therapeutic concentrations in critically ill patients? A longitudinal study over an entire antibiotic course.
    Carlier M; Carrette S; Stove V; Verstraete AG; De Waele JJ
    Int J Antimicrob Agents; 2014 May; 43(5):470-3. PubMed ID: 24685990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains.
    Adnan S; Li JX; Wallis SC; Rudd M; Jarrett P; Paterson DL; Lipman J; Udy AA; Roberts JA
    Int J Antimicrob Agents; 2013 Jul; 42(1):90-3. PubMed ID: 23590897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inadequate antimicrobial prophylaxis during surgery: a study of beta-lactam levels during burn debridement.
    Dalley AJ; Lipman J; Venkatesh B; Rudd M; Roberts MS; Cross SE
    J Antimicrob Chemother; 2007 Jul; 60(1):166-9. PubMed ID: 17504805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for Guillain-Barré syndrome in the US hospitals.
    Alshekhlee A; Hussain Z; Sultan B; Katirji B
    J Clin Neuromuscul Dis; 2008 Sep; 10(1):4-10. PubMed ID: 18772694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saturable elimination of piperacillin in critically ill patients: implications for continuous infusion.
    Dhaese SAM; Colin P; Willems H; Heffernan A; Gadeyne B; Van Vooren S; Depuydt P; Hoste E; Stove V; Verstraete AG; Lipman J; Roberts JA; De Waele JJ
    Int J Antimicrob Agents; 2019 Dec; 54(6):741-749. PubMed ID: 31479741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
    Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
    Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the pharmacokinetics of piperacillin and sulbactam during intermittent and continuous intravenous infusion.
    Langgartner J; Lehn N; Glück T; Herzig H; Kees F
    Chemotherapy; 2007; 53(5):370-7. PubMed ID: 17785973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?
    Roberts JA; Lipman J; Blot S; Rello J
    Curr Opin Crit Care; 2008 Aug; 14(4):390-6. PubMed ID: 18614901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of piperacillin exposure in the lungs of critically ill patients and healthy volunteers.
    Felton TW; Ogungbenro K; Boselli E; Hope WW; Rodvold KA
    J Antimicrob Chemother; 2018 May; 73(5):1340-1347. PubMed ID: 29385448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
    Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A
    Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.